Trial ID or NCT#



not recruiting iconNOT RECRUITING


This extended clinical investigation is a multicenter, prospective, sing arm study intended to provide continued access of the Exablate(R) Model 2100 device (Exablate Prostate) to patients for treatment of prostate lesions and collect additional safety and effectiveness data during the 510(k) preparation and review period.

Official Title

A Continued Access Study to Evaluate Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Eligibility Criteria

Ages Eligible for Study: Older than 50 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No


Geoffrey Sonn
Geoffrey Sonn
Urologic oncologist, Urologist, Urologic specialist, Genitourinary specialist, Urologic surgeon
Assistant Professor of Urology and, by courtesy, of Radiology

Contact us to find out if this trial is right for you.


Ned U. Realiza
(650) 498-8496